Off Patent
October 2026

Androgel

testosterone

Besins Healthcare Ireland Ltd

Gel, metered (transdermal); Gel (transdermal) · NDA 022309

Last listed protection ends
October 12, 2026

The FDA lists 8 patents for Androgel, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 8,466,136
    Claims the drug product
  2. Patent 8,466,137
    Claims a use (U-1103)
  3. Patent 8,466,138
    Claims a use (U-1103)
  4. Patent 8,486,925
    Claims the drug product
  5. Patent 8,729,057
    Claims the drug product
  6. Patent 8,741,881
    Claims a use (U-1103)
  7. Patent 8,754,070
    Claims the drug product
  8. Patent 8,759,329
    Claims the drug product